News

Only musculoskeletal conditions accounted for a greater share of visits

Light gradient boosting machine learning model achieved performance comparing favorably with experienced clinicians

Cumulative incidence of full cognitive recovery higher with postoperative SRS versus WBRT and for SRS alone versus SR + WBRT

No differences seen for quality of life and tumor control with localized prostate cancer

Additional benefits would be seen for extended life expectancy from birth

Long-term efficacy seen for lebrikizumab every two weeks or every four weeks in moderate-to-severe atopic dermatitis

Potential disparities in uptake seen by socioeconomic status and locality among privately insured adults

Carotid plaque burden and coronary artery calcium score both significantly linked to all-cause mortality in asymptomatic individuals

Better remission and response seen with bright light therapy before four weeks and after four weeks

Substantial acute decline seen in global cognition and all cognitive domains; accelerated decline also seen in global cognition